Green Cross-MSD’s strengthened bond in vaccine through co-promotion for ‘Gardasil’

On the 19^th, Green Cross(CEO Eun-Cheol Huh) announced a co-promotion agreement of the MSD’s singles vaccine and cervical cancer, ‘Zostavax’ and ‘Gardasil & Gardasil 9,’ with MSD Korea on the 18^th.

Under the agreement, Green Cross and MSD Korea will jointly promote and market ‘Zostavax’ and ‘Gardasil & Gardasil 9’ for 3 years in Korea by the end of 2019. Moreover, these products will be distrib...